医学
磷酸西他列汀
二甲双胍
2型糖尿病
维尔达格利普汀
肠促胰岛素
临床试验
减肥
胰高血糖素样肽1受体
药理学
糖尿病
内科学
内分泌学
受体
肥胖
兴奋剂
摘要
GLP-1RAs provide superior glycaemic control and weight loss vs. DPP-4 inhibitors in patients with T2D. DPP-4 inhibitors may sometimes be preferred to a GLP-1RA if weight is not a concern, oral administration is a desirable feature or when a GLP-1RA cannot be tolerated.
科研通智能强力驱动
Strongly Powered by AbleSci AI